| Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ... The Lancet Neurology 18 (12), 1091-1102, 2019 | 1674 | 2019 |
| The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire KR Chaudhuri, C Prieto‐Jurcynska, Y Naidu, T Mitra, B Frades‐Payo, ... Movement Disorders 25 (6), 704-709, 2010 | 475 | 2010 |
| Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale P Martínez-Martín, C Rodríguez-Blázquez, M Alvarez, T Arakaki, VC Arillo, ... Parkinsonism & related disorders 21 (1), 50-54, 2015 | 327 | 2015 |
| Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study PJ Garcia-Ruiz, JCM Castrillo, A Alonso-Canovas, AH Barcenas, L Vela, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (8), 840-844, 2014 | 295 | 2014 |
| Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study PJ Garcia Ruiz, Á Sesar Ignacio, B Ares Pensado, A Castro Garcia, ... Movement disorders: official journal of the Movement Disorder Society 23 (8 …, 2008 | 266 | 2008 |
| Expanded and independent validation of the movement disorder society–unified Parkinson’s disease rating scale (MDS-UPDRS) P Martinez-Martin, C Rodriguez-Blazquez, M Alvarez-Sanchez, T Arakaki, ... Journal of neurology 260, 228-236, 2013 | 261 | 2013 |
| Expert consensus group report on the use of apomorphine in the treatment of Parkinson's disease–clinical practice recommendations C Trenkwalder, KR Chaudhuri, PJG Ruiz, P LeWitt, R Katzenschlager, ... Parkinsonism & related disorders 21 (9), 1023-1030, 2015 | 175 | 2015 |
| Assessing the non‐motor symptoms of Parkinson's disease: MDS‐UPDRS and NMS Scale P Martinez‐Martin, KR Chaudhuri, JM Rojo‐Abuin, ... European Journal of Neurology 22 (1), 37-43, 2015 | 151 | 2015 |
| Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ... JAMA neurology 78 (4), 464-472, 2021 | 130 | 2021 |
| Differences in MDS‐UPDRS scores based on Hoehn and Yahr stage and disease duration M Skorvanek, P Martinez‐Martin, N Kovacs, M Rodriguez‐Violante, ... Movement disorders clinical practice 4 (4), 536-544, 2017 | 118 | 2017 |
| Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset KJ Billingsley, IA Barbosa, S Bandrés-Ciga, JP Quinn, VJ Bubb, ... npj Parkinson's Disease 5 (1), 8, 2019 | 106 | 2019 |
| The SCOPA–Motor Scale for assessment of Parkinson's disease is a consistent and valid measure P Martínez-Martín, J Benito-León, JA Burguera, A Castro, G Linazasoro, ... Journal of clinical epidemiology 58 (7), 674-679, 2005 | 100 | 2005 |
| Pallidal stimulation relieves myoclonus–dystonia syndrome CM Magarinos-Ascone, I Regidor, JC Martinez-Castrillo, M Gomez-Galan, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (7), 989-991, 2005 | 99 | 2005 |
| Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability RH Reynolds, J Botía, MA Nalls, J Hardy, SA Gagliano Taliun, M Ryten npj Parkinson's Disease 5 (1), 6, 2019 | 90 | 2019 |
| The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease C Rodriguez-Blazquez, JM Rojo-Abuin, M Alvarez-Sanchez, T Arakaki, ... Parkinsonism & related disorders 19 (10), 889-893, 2013 | 85 | 2013 |
| Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results … D Santos-García, T Deus Fonticoba, SC Ester, C Borrué, M Mata, ... Elsevier, 2019 | 84 | 2019 |
| Relationship between the MDS‐UPDRS domains and the health‐related quality of life of P arkinson's disease patients P Martínez‐Martín, C Rodríguez‐Blázquez, MJ Forjaz, ... European Journal of Neurology 21 (3), 519-524, 2014 | 76 | 2014 |
| Relationship between the MDS-UPDRS and quality of life: a large multicenter study of 3206 patients M Skorvanek, P Martinez-Martin, N Kovacs, I Zezula, ... Parkinsonism & related disorders 52, 83-89, 2018 | 72 | 2018 |
| Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score H Iwaki, C Blauwendraat, MB Makarious, S Bandrés‐Ciga, HL Leonard, ... Movement Disorders 35 (5), 774-780, 2020 | 64 | 2020 |
| Advanced Parkinson's disease: clinical characteristics and treatment. Part II J Kulisevsky, MR Luquin, JM Arbelo, JA Burguera, F Carrillo, A Castro, ... Neurología (English Edition) 28 (9), 558-583, 2013 | 59 | 2013 |
